{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:26:07Z","timestamp":1782915967159,"version":"3.54.5"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Norway does not currently implement universal varicella vaccination in childhood. We aimed to characterize health care burden of varicella in Norway in the prevaccine era.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We linked individual patient data from different national registries to examine varicella vaccinations and varicella-coded primary care consultations, hospitalizations, outpatient hospital visits, deaths and viral infections of central nervous system in the whole population of Norway during 2008\u20132014. We estimated health care contact rates and described the epidemiology of medically attended varicella infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Each year approximately 14,600 varicella-related contacts occurred within primary health care and hospital sector in Norway. The annual contact rate was 221 cases per 100,000 population in primary health care and 7.3 cases per 100,000 in hospital care. Both in primary and hospital care, the highest incidences were observed among children 1 year of age: 2,654 and 78.1 cases per 100,000, respectively. The annual varicella mortality was estimated at 0.06 deaths per 100,000 and in-hospital case-fatality rate at 0.3%. Very few (0.2\u22120.5%) patients were vaccinated against varicella. Among hospitalized varicella patients, 22% had predisposing conditions, 9% had severe-to-very severe comorbidities and 5.5% were immunocompromised. Varicella-related complications were reported in 29.3% of hospitalized patients. Varicella zoster virus was the third most frequent virus found among 16% of patients with confirmed viral infections of central nervous system.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Varicella causes a considerable health care burden in Norway, especially among children. To inform the policy decision on the use of varicella vaccination, a health economic assessment of vaccination and mathematical modeling of vaccination impact are needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001656","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T15:00:05Z","timestamp":1498662005000},"page":"1032-1038","source":"Crossref","is-referenced-by-count":14,"title":["Varicella-related Primary Health-care Visits, Hospitalizations and Mortality in Norway, 2008\u20132014"],"prefix":"10.1097","volume":"36","author":[{"given":"Grazina","family":"Mirinaviciute","sequence":"first","affiliation":[{"name":"Section for Research and Development, Department of Pediatrics and Adolescent Medicine, Akershus University Hospital, Nordbyhagen, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erle","family":"Kristensen","sequence":"additional","affiliation":[{"name":"Section for Research and Development, Department of Pediatrics and Adolescent Medicine, Akershus University Hospital, Nordbyhagen, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Nakstad","sequence":"additional","affiliation":[{"name":"Section for Research and Development, Department of Pediatrics and Adolescent Medicine, Akershus University Hospital, Nordbyhagen, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Flem","sequence":"additional","affiliation":[{"name":"Section for Research and Development, Department of Pediatrics and Adolescent Medicine, Akershus University Hospital, Nordbyhagen, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella.","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"issue":"3 Suppl","key":"R2-20230912","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/erv.10.30","article-title":"Herpes zoster and postherpetic neuralgia.","volume":"9","author":"Johnson","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1016\/j.vaccine.2007.07.036","article-title":"The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.","volume":"25","author":"Nardone","year":"2007","journal-title":"Vaccine"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1741-7015-7-26","article-title":"Varicella vaccination in Europe\u2014taking the practical approach.","volume":"7","author":"Bonanni","year":"2009","journal-title":"BMC Med"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2015.06.004","article-title":"Varicella-zoster virus infections of the central nervous system\u2014prognosis, diagnostics and treatment.","volume":"71","author":"Grahn","year":"2015","journal-title":"J Infect"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/00365548.2012.719634","article-title":"Infectious encephalitis: a description of a Norwegian cohort.","volume":"45","author":"Quist-Paulsen","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1212\/WNL.0000000000001409","article-title":"Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis.","volume":"84","author":"Gilden","year":"2015","journal-title":"Neurology"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/j.vaccine.2014.04.034","article-title":"Low varicella-related consultation rate in The Netherlands in primary care data.","volume":"32","author":"van Lier","year":"2014","journal-title":"Vaccine"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.vaccine.2006.02.017","article-title":"The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.","volume":"24","author":"de Melker","year":"2006","journal-title":"Vaccine"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1017\/S0950268811002640","article-title":"The health and economic burden of chickenpox and herpes zoster in Belgium.","volume":"140","author":"Bilcke","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"Suppl 1","key":"R12-20230912","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/jmv.10313","article-title":"Epidemiology of varicella-zoster virus in England and Wales.","volume":"70","author":"Brisson","year":"2003","journal-title":"J Med Virol"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1017\/S0950268803008690","article-title":"Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia.","volume":"131","author":"MacIntyre","year":"2003","journal-title":"Epidemiol Infect"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0264-410X(01)00370-X","article-title":"Epidemiology of primary varicella hospitalizations in Spain.","volume":"20","author":"Gil","year":"2001","journal-title":"Vaccine"},{"key":"R16-20230912","first-page":"219","article-title":"Chickenpox in Poland in 2013.","volume":"69","author":"Korczynska","year":"2015","journal-title":"Przeglad epidemiologiczny"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2015.03.055","article-title":"Varicella in Europe\u2014a review of the epidemiology and experience with vaccination.","volume":"33","author":"Helmuth","year":"2015","journal-title":"Vaccine"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jinf.2016.05.008","article-title":"The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.","volume":"73","author":"Hobbelen","year":"2016","journal-title":"J Infect"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"e60732","DOI":"10.1371\/journal.pone.0060732","article-title":"Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.","volume":"8","author":"Poletti","year":"2013","journal-title":"PLoS One"},{"key":"R21-20230912","first-page":"9","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis.","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"e66485","DOI":"10.1371\/journal.pone.0066485","article-title":"Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review.","volume":"8","author":"Ogunjimi","year":"2013","journal-title":"PLoS One"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.4045\/tidsskr.15.1028","article-title":"MSIS celebrates 40 years.","volume":"135","author":"L\u00f8vlie","year":"2015","journal-title":"Tidsskr Nor Laegeforen"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12879-016-1369-6","article-title":"Hospital-based herpes zoster diagnoses in Denmark: rate, patient characteristics, and all-cause mortality.","volume":"16","author":"Schmidt","year":"2016","journal-title":"BMC Infect Dis"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/INF.0000000000001347","article-title":"Children hospitalized with varicella in Denmark: sensitivity of the national patient register.","volume":"36","author":"Glode Helmuth","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jinf.2016.04.035","article-title":"Varicella-zoster virus (VZV) DNA in serum of patients with VZV central nervous system infections.","volume":"73","author":"Grahn","year":"2016","journal-title":"J Infect"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.052","article-title":"Varicella zoster virus: a common cause of stroke in children and adults.","volume":"25","author":"Amlie-Lefond","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R32-20230912","first-page":"65","article-title":"Norsk pasientregister: Administrativ database med mange forskningsmuligheter [The Norwegian Patient Registry].","volume":"14","author":"Bakken","year":"2004","journal-title":"Norsk Epidemiologi"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4045\/tidsskr.13.1417","article-title":"[The Norwegian patient register\u2014an important source for research].","volume":"134","author":"Bakken","year":"2014","journal-title":"Tidsskr Nor Laegeforen"},{"key":"R34-20230912","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jclinepi.2009.01.010","article-title":"Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995.","volume":"62","author":"Johansson","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4045\/tidsskr.14.1065","article-title":"Data quality in the causes of death registry.","volume":"135","author":"Pedersen","year":"2015","journal-title":"Tidsskr Nor Laegeforen"},{"key":"R36-20230912","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1542\/peds.2010-3385","article-title":"Near elimination of varicella deaths in the US after implementation of the vaccination program.","volume":"128","author":"Marin","year":"2011","journal-title":"Pediatrics"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2016.02.040","article-title":"Strong Additional Effect of a Second Varicella Vaccine Dose in Children in Germany, 2009\u20132014.","volume":"173","author":"Siedler","year":"2016","journal-title":"J Pediatr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201711000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:12:19Z","timestamp":1694556739000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201711000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001656","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}